Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A bipartisan continuing resolution passed by the House 370–48 would temporarily block the Office of Management and Budget from overhauling the federal grantmaking process. If signed by President Trump, the changes — which would replace peer review with political appointee decision-making — can't be implemented until Dec. 11. Medical societies like IDSA and HIVMA are applauding the move but calling for a permanent fix.
Congress just hit pause on a controversial federal grant overhaul. The House passed H.R. 6500 on Sept. 1 in a strong bipartisan vote, and if President Trump signs it, the continuing resolution will temporarily prevent the Office of Management and Budget (OMB) from finalizing sweeping changes to how federal grant funding is distributed — at least until Dec. 11.
At the heart of the debate: the OMB had proposed scrapping the traditional peer-review process in favor of a system where political appointees decide what gets funded — and federal officials could cancel grants at any time. Critics called it an "unprecedented shift" that could gut medical research and public health infrastructure.
The Infectious Diseases Society of America (IDSA) and HIV Medicine Association (HIVMA) praised Congress for the swift, bipartisan action, but made clear this is only a temporary reprieve — urging lawmakers to enact a long-term solution.
Key Takeaways:
Why it matters: Federal grants are the backbone of U.S. medical research and public health programs. Replacing merit-based peer review with political oversight could have far-reaching consequences for disease prevention, treatment innovation, and public health readiness — making this policy fight one to watch closely.
